Astellas Announces Management Structure

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the following changes to its management...

Related Keywords

China ,Japan ,Tokyo ,London ,City Of ,United Kingdom ,Banyu ,Shanxi ,Kenji Yasukawa ,Hideki Shima ,Naoki Okamura ,Catherine Levitt ,Fumiaki Sakurai ,Bristol Myers Squibb ,Yoshitsugu Shitaka ,Bernhardt Zeiher ,Katsuyoshi Sugita ,Yukio Matsui ,Minoru Kikuoka ,Johnson ,Tadaaki Taniguchi ,Asahi Kasei Corp ,Infectious Disease Center Hospital ,Solutions Corp ,Head Of Research Development Japan ,China Development ,Itochu ,Head Of Global Medical Affairs ,Head Of Japan Research Development ,Astellas Pharma Inc ,Clinical Research ,Hilti Japan Ltd ,Division Head Of Human Resources ,Deputy Head Of Japan Development ,Clinical Development Institute ,Deputy Head Of Clinical Development Institute ,Organizational Health Goals ,Clinical Sciences ,Imperial Cancer Research Fund ,Global Medicine Development ,Microsoft Japan Co Ltd ,Banyu Pharmaceutical Co Ltd ,Prnewswire Astellas Pharma Inc ,Chief Medical Officer ,Executive Advisor ,Chief Administrative Officer ,Chief Ethics ,Compliance Officer ,Chief People Officer ,Human Resources ,Strategic Plan ,Corporate Strategic Plan ,Effective October ,Chief Excecutive Officer ,Executive Vice President ,Strategy Officer ,Commercial Officer ,Scientific Officer ,Financial Officer ,Manufacturing Officer ,Medical Officer ,People Officer ,Corporate Officer ,Executive Adviser ,Division Head ,Effective September ,Astellas Pharma ,Oncology Business Unit Asia Strategy ,Global Medical Affairs ,Oncology Business Unit ,Development Japan ,Japan Research ,Strategic Officer ,Deputy Head ,Japan Development ,Research Fellow ,Molecular Pathology Unit ,Hammersmith Hospital ,Tokyo Metropolitan Oncology ,Infectious Disease Center ,Human Resources Head ,Hilti Japan ,Focus Area Approach ,